APEA PHARMACOLOGY COMPREHENSIVE EXAM
250 Practice Questions with ANSWERs &
Rationales 2026
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1-25)
Question 1
Pharmacokinetics is defined as:
A) What the drug does to the body
B) The effect the body has on the drug
C) The study of drug toxicity
D) The mechanism of drug action at receptor sites
ANSWER: B) The effect the body has on the drug
Rationale: Pharmacokinetics encompasses the processes of Absorption, Distribution, Metabolism, and
Excretion (ADME)—what the body does to the drug. Pharmacodynamics is what the drug does to the
body.
Question 2
Pharmacodynamics is defined as:
A) The effect the body has on the drug
B) The study of drug absorption
C) What the drug does to the body
,D) The rate of drug elimination
ANSWER: C) What the drug does to the body
Rationale: Pharmacodynamics describes the biochemical and physiologic effects of drugs and their
mechanisms of action at receptor sites, including therapeutic and adverse effects.
Question 3
The time it takes for the plasma concentration of a drug to be reduced to half of its original value is
known as:
A) Steady state
B) Therapeutic window
C) Half-life
D) Bioavailability
ANSWER: C) Half-life
Rationale: Half-life (t½) determines dosing frequency and time to steady state. Approximately 4-5 half-
lives are required to reach steady state. Half-life is critical for determining dosing intervals and
predicting drug accumulation.
Question 4
Steady state is achieved when:
A) The drug is first administered
B) The rate of drug input equals the rate of drug elimination
C) The drug reaches its peak concentration
D) The drug is completely eliminated from the body
ANSWER: B) The rate of drug input equals the rate of drug elimination
,Rationale: Steady state occurs when drug administration and elimination are in balance, resulting in
consistent plasma drug levels. This typically requires 4-5 half-lives of regular dosing.
Question 5
To calculate approximately how long it will take to reach steady state of a drug, the clinician should
multiply the half-life of the drug times:
A) 3
B) 4
C) 5
D) 6
ANSWER: C) 5
Rationale: The time taken to reach steady state is about 5 times the half-life of a drug. Drugs like digoxin
and warfarin with a long half-life will take longer to reach a steady state than drugs with a shorter half-
life.
Question 6
The correct sequence of the movement of a drug through the body is:
A) Absorption, metabolism, distribution, excretion
B) Absorption, distribution, metabolism, excretion
C) Distribution, absorption, metabolism, excretion
D) Metabolism, absorption, distribution, excretion
ANSWER: B) Absorption, distribution, metabolism, excretion
Rationale: The correct sequence is ADME: Absorption (drug enters circulation), Distribution (drug
disperses to tissues), Metabolism (drug is biotransformed), and Excretion (drug is eliminated from the
body).
Question 7
, Pharmacodynamic interactions that occur when two drugs act on distinct receptors is known as:
A) Homodynamic competitors
B) Heterodynamic competitors
C) Metabolic competitors
D) Transport competitors
ANSWER: B) Heterodynamic competitors
Rationale: A drug interaction occurs when a substance affects the activity of a drug when both are
administered together. An interaction between two drugs that act on distinct receptors are referred to
as heterodynamic competitors. If the two drugs act on the same receptor, they are referred to as
homodynamic competitors.
Question 8
A nurse practitioner is initiating pharmacotherapy for an elderly patient with multiple chronic
comorbidities. Which age-related pharmacokinetic change must the clinician consider to avoid drug
toxicity?
A) Increased renal clearance of hydrophilic drugs
B) Increased hepatic blood flow leading to rapid first-pass metabolism
C) Increased percentage of body fat leading to a prolonged half-life of lipophilic drugs
D) Decreased gastric pH impairing the absorption of acidic medications
ANSWER: C) Increased percentage of body fat leading to a prolonged half-life of lipophilic drugs
Rationale: Aging alters body composition by increasing total body fat and decreasing lean muscle mass
and total body water. Consequently, highly lipophilic (fat-soluble) drugs exhibit an increased volume of
distribution and a prolonged elimination half-life in older adults, significantly elevating the risk of
cumulative toxicity.
Question 9
Bioavailability refers to:
A) The percentage of drug that reaches systemic circulation
250 Practice Questions with ANSWERs &
Rationales 2026
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1-25)
Question 1
Pharmacokinetics is defined as:
A) What the drug does to the body
B) The effect the body has on the drug
C) The study of drug toxicity
D) The mechanism of drug action at receptor sites
ANSWER: B) The effect the body has on the drug
Rationale: Pharmacokinetics encompasses the processes of Absorption, Distribution, Metabolism, and
Excretion (ADME)—what the body does to the drug. Pharmacodynamics is what the drug does to the
body.
Question 2
Pharmacodynamics is defined as:
A) The effect the body has on the drug
B) The study of drug absorption
C) What the drug does to the body
,D) The rate of drug elimination
ANSWER: C) What the drug does to the body
Rationale: Pharmacodynamics describes the biochemical and physiologic effects of drugs and their
mechanisms of action at receptor sites, including therapeutic and adverse effects.
Question 3
The time it takes for the plasma concentration of a drug to be reduced to half of its original value is
known as:
A) Steady state
B) Therapeutic window
C) Half-life
D) Bioavailability
ANSWER: C) Half-life
Rationale: Half-life (t½) determines dosing frequency and time to steady state. Approximately 4-5 half-
lives are required to reach steady state. Half-life is critical for determining dosing intervals and
predicting drug accumulation.
Question 4
Steady state is achieved when:
A) The drug is first administered
B) The rate of drug input equals the rate of drug elimination
C) The drug reaches its peak concentration
D) The drug is completely eliminated from the body
ANSWER: B) The rate of drug input equals the rate of drug elimination
,Rationale: Steady state occurs when drug administration and elimination are in balance, resulting in
consistent plasma drug levels. This typically requires 4-5 half-lives of regular dosing.
Question 5
To calculate approximately how long it will take to reach steady state of a drug, the clinician should
multiply the half-life of the drug times:
A) 3
B) 4
C) 5
D) 6
ANSWER: C) 5
Rationale: The time taken to reach steady state is about 5 times the half-life of a drug. Drugs like digoxin
and warfarin with a long half-life will take longer to reach a steady state than drugs with a shorter half-
life.
Question 6
The correct sequence of the movement of a drug through the body is:
A) Absorption, metabolism, distribution, excretion
B) Absorption, distribution, metabolism, excretion
C) Distribution, absorption, metabolism, excretion
D) Metabolism, absorption, distribution, excretion
ANSWER: B) Absorption, distribution, metabolism, excretion
Rationale: The correct sequence is ADME: Absorption (drug enters circulation), Distribution (drug
disperses to tissues), Metabolism (drug is biotransformed), and Excretion (drug is eliminated from the
body).
Question 7
, Pharmacodynamic interactions that occur when two drugs act on distinct receptors is known as:
A) Homodynamic competitors
B) Heterodynamic competitors
C) Metabolic competitors
D) Transport competitors
ANSWER: B) Heterodynamic competitors
Rationale: A drug interaction occurs when a substance affects the activity of a drug when both are
administered together. An interaction between two drugs that act on distinct receptors are referred to
as heterodynamic competitors. If the two drugs act on the same receptor, they are referred to as
homodynamic competitors.
Question 8
A nurse practitioner is initiating pharmacotherapy for an elderly patient with multiple chronic
comorbidities. Which age-related pharmacokinetic change must the clinician consider to avoid drug
toxicity?
A) Increased renal clearance of hydrophilic drugs
B) Increased hepatic blood flow leading to rapid first-pass metabolism
C) Increased percentage of body fat leading to a prolonged half-life of lipophilic drugs
D) Decreased gastric pH impairing the absorption of acidic medications
ANSWER: C) Increased percentage of body fat leading to a prolonged half-life of lipophilic drugs
Rationale: Aging alters body composition by increasing total body fat and decreasing lean muscle mass
and total body water. Consequently, highly lipophilic (fat-soluble) drugs exhibit an increased volume of
distribution and a prolonged elimination half-life in older adults, significantly elevating the risk of
cumulative toxicity.
Question 9
Bioavailability refers to:
A) The percentage of drug that reaches systemic circulation
